Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Fulminant response to combined checkpoint inhibition with ipilimumab plus nivolumab after failure of nivolumab monotherapy in metastatic melanoma

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Cancer - Volume 83, September 2017, Pages 142-145

Selma Ugurel, Felix Kiecker, Stefan Fröhling, Axel Wetter, Agnes Bankfalvi, Antje Sucker, Lisa Zimmer, Elisabeth Livingstone, Alexander Roesch, Jürgen C. Becker, Dirk Schadendorf,